Last-resort antibiotic excluded from Belgian system, testing EU pharma reforms

EURACTIV - A critical antibiotic designed to treat infections caused by multidrug-resistant bacteria will remain unavailable through Belgium's reimbursement system after negotiations between the government and the manufacturer failed. Read more

Photo by Jacob Wackerhausen / Getty Images